The NIPT by GenePlanet is a highly accurate non-invasive prenatal test that screens for chromosomal aneuploidies, including trisomies 21, 18 and 13, after week 10 of pregnancy onward. The test provides significantly stronger risk indication than traditional screening procedures. With a sensitivity rate of >99 % (validated on over 147,000 pregnancies) and a false positive rate of just 0,12 % for trisomies 21, 18 and 13, our test ensures that the number of women undergoing unnecessary invasive diagnostic procedures is significantly reduced.
To this date, over 5.000.000 NIPT samples with our technology have been processed worldwide.
Contact us and we will help you find the answers.